Edward Shoen (Chair and CEO since 1987) purchased $2.1 million of stock on the 15th December at $428.55. His previous buys, such as in 2009 have been well timed and whilst he started buying too early in 2020 he continued to average down and ultimately those trades worked out very well. This latest purchase, through […]
Walter Powell (Chief Accounting Officer since 2017) purchased $194,000 of stock on the 4th December at $6.81 in his first trade in the company, David Quinn (CFO since 2020) purchased $436,000 of stock on the 3rd December. Leonard Lemoine (Non-Executive Director) bought $189,000 of stock, Lonnie Boyer (CEO since 2017) purchased $60,000 and Gary Cappa […]
Carl Hull (Co-founder and CEO since 2014) purchased $942,000 of stock on the 25th of November at $26.94. The company recently floated at $27. There was significant subscription by both directors and executives in the IPO with 5 directors spending in total over $3 million and 2 executives spending in total over $700,000. The number […]
Hutham Olayan (Director since 2006) purchased 25,000 shares on November 12th at $55.40, spending $1.4m and increasing her holdings to 218,478 shares. This is Olayan’s third open market buy since joining the board 14 years ago and is by far her largest. Her last purchase was in 2011 at $20. We were also intrigued to […]
Anthony Jabbour (CEO since 2020) purchased $1 million of stock on the 6th of November at $26.31. This is his first purchase since the IPO in July 2020 when he subscribed for $4.4 million at $22. He only made 3 purchases when CEO at Black Knight but they were well-timed. Bryan Hipsher (CFO since 2020) […]
After seeing a cluster of four directors, the Chairman, a Divisional President, the CEO and CFO all buy shares on September 21st, one of the buyers, Allen Hugli (Director) has made an additional purchase spending $160,000 at $15.97. This is a solid show of confidence from board members and officers, and a mixture of buying […]
Albert Bourla’s sale of $5.5m of stock on the announcement of Pfizer’s Covid-19 vaccine success generated significant headlines as it represented 62% of his equity holding. When ranking stocks a key point we look at is the sale relative to their total holding. In the US executives typically have options that are exercisable to become […]
Gregory Hayes (CEO since 2020, first joined 2003) purchased $3 million of stock on the 28th Oct at US$54.82. This is his first ever purchase and he has been a regular seller, crystalising approx $24 million through option sales (net of the option cost). Thomas Kennedy (Chairman since 2020, previously CEO of Raytheon from 2016 […]
Harley-Davidson reported encouraging Q3 results earlier this week. The shares are now up over 20% since we positively ranked them on CEO buying on the 14th of August. This is what we said at the time: Jochen Zeitz (Chair and CEO since May 2020, Non-Exec since 2007) purchased $2 million of stock at $27.86 on […]
Pandora upgraded expectations again last week. We originally positively rated the stock on the 17th March on director buying and then rated it positively again on further buying on 26th August. The shares are now up 140% from our first positive ranking and 20% from our latest upgrade. This is what we said: Alexander Lacik […]